GLP-one course compounds. Semaglutide, tirzepatide, and liraglutide are authorised medicinal goods from the Netherlands and have elevated regulatory and import scrutiny. Any framing that presents them as therapeutic choices to prescription medicines delivers them underneath the Geneesmiddelenwet and its promoting rules, which the IGJ actively enfor